Your browser doesn't support javascript.
loading
Outcomes of patients admitted with malignant small bowel obstruction: a subgroup multicentre observational cohort analysis.
Hupfeld, N B; Burcharth, J; Jensen, T K; Lolle, I; Nielsen, L B J; Tolver, M A; Skovsen, A P; Smith, H G.
Afiliação
  • Hupfeld NB; Department of Surgery, Copenhagen University Hospital-North Zealand, Hilleroed, Denmark. nanna.baekvang.hupfeld@regionh.dk.
  • Burcharth J; Department of Gastrointestinal and Hepatic Diseases, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
  • Jensen TK; Department of Gastrointestinal and Hepatic Diseases, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
  • Lolle I; Department of Surgery, Copenhagen University Hospital-Amager and Hvidovre, Hvidovre, Denmark.
  • Nielsen LBJ; Digestive Disease Center, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Copenhagen, Denmark.
  • Tolver MA; Department of Surgery, Sjaelland University Hospital, Koege, Denmark.
  • Skovsen AP; Department of Surgery, Copenhagen University Hospital-North Zealand, Hilleroed, Denmark.
  • Smith HG; Digestive Disease Center, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Copenhagen, Denmark.
Langenbecks Arch Surg ; 409(1): 239, 2024 Aug 06.
Article em En | MEDLINE | ID: mdl-39105830
ABSTRACT
INTRODUCTION AND PURPOSE OF THE STUDY Small bowel obstruction (SBO) accounts for a substantial proportion of emergency surgical admissions. Malignancy is a common cause of obstruction, either due to a primary tumour or intra-abdominal metastases. However, little is known regarding the current treatment or outcomes of patients with malignant SBO. This study aimed to characterise the treatment of malignant SBO and identify areas for potential improvement and compare overall survival of patients with malignant SBO to patients with non-malignant SBO. MATERIALS AND

METHODS:

This was a subgroup analysis of a multicentre observational study of patients admitted with SBO. Details regarding these patients' diagnoses, treatments, and outcomes up to 1-year after admission were recorded. The primary outcome was overall survival in patients with malignant SBO.

RESULTS:

A total of 316 patients with small bowel obstruction were included, of whom 33 (10.4%) had malignant SBO. Out of the 33 patients with malignant SBO, 20 patients (60.6%) were treated with palliative intent although only 7 patients were seen by a palliative team during admission. Nutritional assessments were performed on 12 patients, and 11 of these patients received parenteral nutrition. 23 patients underwent surgery, with the most common surgical interventions being loop ileostomies (9 patients) and gastrointestinal bypasses (9 patients). 4 patients underwent right hemicolectomies, with a primary anastomosis formed and 1 patient had a right hemicolectomy with a terminal ileostomy. Median survival was 114 days, and no difference was seen in survival between patients treated with or without palliative intent.

CONCLUSION:

Malignant SBO is associated with significant risks of short-term complications and a poor prognosis. Consideration should be given to the early involvement of senior decision-makers upon patient admission is essential for optimal management and setting expectation for a realistic outcome.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cuidados Paliativos / Obstrução Intestinal / Intestino Delgado Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cuidados Paliativos / Obstrução Intestinal / Intestino Delgado Idioma: En Ano de publicação: 2024 Tipo de documento: Article